BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31377208)

  • 21. The role of CD68+ macrophage in classical Hodgkin lymphoma patients from Egypt.
    Mohamed O; El Bastawisy A; Allahlobi N; Abdellateif MS; Zekri ARN; Shaarawy S; Korany Z; Mohanad M; Bahnassy AA
    Diagn Pathol; 2020 Feb; 15(1):10. PubMed ID: 32019558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation of viable Hodgkin and Reed-Sternberg cells from Hodgkin disease tissues.
    Irsch J; Nitsch S; Hansmann ML; Rajewsky K; Tesch H; Diehl V; Jox A; Küppers R; Radbruch A
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10117-22. PubMed ID: 9707610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spindle-shaped CD163+ rosetting macrophages replace CD4+ T-cells in HIV-related classical Hodgkin lymphoma.
    Hartmann S; Jakobus C; Rengstl B; Döring C; Newrzela S; Brodt HR; Wolf T; Hansmann ML
    Mod Pathol; 2013 May; 26(5):648-57. PubMed ID: 23307058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD68 staining correlates with the size of residual mass but not with survival in classical Hodgkin lymphoma.
    Agur A; Amir G; Paltiel O; Klein M; Dann EJ; Goldschmidt H; Goldschmidt N
    Leuk Lymphoma; 2015 May; 56(5):1315-9. PubMed ID: 25204373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoglobulin gene rearrangement analysis in composite hodgkin disease and large B-cell lymphoma: evidence for receptor revision of immunoglobulin heavy chain variable region genes in Hodgkin-Reed-Sternberg cells?
    Bellan C; Lazzi S; Zazzi M; Lalinga AV; Palummo N; Galieni P; Marafioti T; Tonini T; Cinti C; Leoncini L; Pileri SA; Tosi P
    Diagn Mol Pathol; 2002 Mar; 11(1):2-8. PubMed ID: 11854595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic Lymphocytic Leukemia With Hodgkin and Reed-Sternberg (HRS) Cells: A Potential Diagnostic Pitfall in Lymph Node Biopsies.
    Agrawal P; Bal A; Das A; Sachdeva M; Prakash G
    Appl Immunohistochem Mol Morphol; 2017 Jan; 25(1):e9-e11. PubMed ID: 26894648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor associated macrophages in relapsed and refractory Hodgkin lymphoma.
    Casulo C; Arcila M; Bohn OL; Teruya-Feldstein J; Maragulia J; Moskowitz CH
    Leuk Res; 2013 Sep; 37(9):1178-83. PubMed ID: 23706570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma.
    Azambuja D; Natkunam Y; Biasoli I; Lossos IS; Anderson MW; Morais JC; Spector N
    Ann Oncol; 2012 Mar; 23(3):736-742. PubMed ID: 21602260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IMP3 as a supplemental diagnostic marker for Hodgkin lymphoma.
    Tang H; Wei Q; Ge J; Jian W; Liu J; Zhong L; Fu B; Zhao T
    Hum Pathol; 2013 Oct; 44(10):2167-72. PubMed ID: 23845468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High CD20+ background cells predict a favorable outcome in classical Hodgkin lymphoma and antagonize CD68+ macrophages.
    Panico L; Tenneriello V; Ronconi F; Lepore M; Cantore N; Dell'Angelo AC; Ferbo L; Ferrara F
    Leuk Lymphoma; 2015 Jun; 56(6):1636-42. PubMed ID: 25098425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphological and immunohistochemical investigation of non-Hodgkin's lymphoma combined with Hodgkin's disease.
    Hansmann ML; Fellbaum C; Hui PK; Lennert K
    Histopathology; 1989 Jul; 15(1):35-48. PubMed ID: 2548946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial.
    Tan KL; Scott DW; Hong F; Kahl BS; Fisher RI; Bartlett NL; Advani RH; Buckstein R; Rimsza LM; Connors JM; Steidl C; Gordon LI; Horning SJ; Gascoyne RD
    Blood; 2012 Oct; 120(16):3280-7. PubMed ID: 22948049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic significance of CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's Lymphoma].
    Fu XH; Wang SS; Huang Y; Xiao J; Zhai LZ; Xia ZJ; Huang HQ; Sun XF; Lin TY
    Ai Zheng; 2008 Nov; 27(11):1197-203. PubMed ID: 19000453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High content of Langerhans cells in malignant lymphoma--incidence and significance.
    Benharroch D; Guterman G; Levy I; Shaco-Levy R
    Virchows Arch; 2010 Jul; 457(1):63-7. PubMed ID: 20473767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CSF-1R expression in tumor-associated macrophages is associated with worse prognosis in classical Hodgkin lymphoma.
    Koh YW; Park C; Yoon DH; Suh C; Huh J
    Am J Clin Pathol; 2014 Apr; 141(4):573-83. PubMed ID: 24619759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells.
    Gruss H-J ; Herrmann F
    Leuk Lymphoma; 1996 Feb; 20(5-6):397-409. PubMed ID: 8833395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic Active Epstein-Barr Virus Infection of T/NK-Cell Type Mimicking Classic Hodgkin Lymphoma: Clinicopathologic and Genetic Features of 8 Cases Supporting a Variant With "Hodgkin/Reed-Sternberg-like" Cells of NK Phenotype.
    Chen Z; Liu W; Zhang W; Ye Y; Guan P; Gao L; Zhao S
    Am J Surg Pathol; 2019 Dec; 43(12):1611-1621. PubMed ID: 31305266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinicopathologic characteristics and prognosis of neoplastic cell-rich mixed cellularity classic Hodgkin lymphoma].
    Hou WH; Wei P; Xie JL; Zheng YY; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2017 Oct; 46(10):708-713. PubMed ID: 29050074
    [No Abstract]   [Full Text] [Related]  

  • 39. HIV-associated Hodgkin lymphoma: a clinicopathologic and immunophenotypic study of 45 cases.
    Thompson LD; Fisher SI; Chu WS; Nelson A; Abbondanzo SL
    Am J Clin Pathol; 2004 May; 121(5):727-38. PubMed ID: 15151213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human CD30+ B cells represent a unique subset related to Hodgkin lymphoma cells.
    Weniger MA; Tiacci E; Schneider S; Arnolds J; Rüschenbaum S; Duppach J; Seifert M; Döring C; Hansmann ML; Küppers R
    J Clin Invest; 2018 Jul; 128(7):2996-3007. PubMed ID: 29889102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.